⌘K

Login Start Free

Home/Filings/4/0001204459-09-001744

4//SEC Filing

Geller Matthew 4

Accession 0001204459-09-001744

CIK 0000875622other

View on SEC.gov Company Profile

Filed

Sep 23, 8:00 PM ET

Accepted

Sep 24, 1:15 PM ET

Size

5.4 KB

Accession

0001204459-09-001744

Insider Transaction Report

Form 4

Period: 2009-09-22

BIOSPECIFICS TECHNOLOGIES CORPBSTC

Director

Transactions

Award
Stock Option (Right to Buy)
2009-09-22+15,000→ 45,000 total
Exercise: $30.79Exp: 2019-09-21→ Common Stock, $.001 par value (15,000 underlying)

Footnotes (1)

[F1]The option vests monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

BIOSPECIFICS TECHNOLOGIES CORP

CIK 0000875622

Entity typeother

Related Parties

1

filerCIK 0001446201

Filing Metadata

Form type: 4
Filed: Sep 23, 8:00 PM ET
Accepted: Sep 24, 1:15 PM ET
Size: 5.4 KB

View on SEC.gov